XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating Income        
Revenue $ 0 $ 0 $ 0 $ 4,000,000
Cost of revenue 0 0 0 (1,600,000)
Gross Profit 0 0 0 2,400,000
Operating Expenses:        
Research and development 3,876,876 3,552,068 11,176,326 11,559,364
General and administrative 3,353,352 2,372,999 10,362,907 6,914,481
Total Operating Expenses 7,230,228 5,925,067 21,539,233 18,473,845
Loss From Operations (7,230,228) (5,925,067) (21,539,233) (16,073,845)
Other Income (Expense):        
Extinguishment of PPP 7(a) loan   463,353 0 463,353
Other income, net 70,277 11,728 96,580 48,880
Interest expense (177,138) (119,212) (475,811) (202,407)
Interest income 28,093 600 30,703 2,354
Net Loss $ (7,308,996) $ (5,568,598) $ (21,887,761) $ (15,761,665)
Net Loss Per Share        
Net Loss Per Share - Basic $ (0.21) $ (0.21) $ (0.67) $ (0.61)
Net Loss Per Share - Diluted $ (0.21) $ (0.21) $ (0.67) $ (0.61)
Weighted Average Number of Common Shares Outstanding        
Weighted Average Number of Common Shares Outstanding - Basic 34,631,774 26,053,532 32,778,551 25,773,098
Weighted Average Number of Common Shares Outstanding - Diluted 34,631,774 26,053,532 32,778,551 25,773,098